MedPath

Self-Propelled Versus Standard Percutaneous Endoscopic Gastrojejunostomy(PEG-J); RCT

Phase 2
Terminated
Conditions
Feeding Tube
Interventions
Device: PEG-J placement
Registration Number
NCT01892267
Lead Sponsor
Johns Hopkins University
Brief Summary

Our main hypothesis is that self-propelled Percutaneous Endoscopic Gastrojejunostomy tube (PEG-J) that has a balloon on it's tip is associated with lower J-tube retrograde migration rate, and lower rates of short- and long-term complications when compared to standard PEGJ feeding tubes.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Consecutive adult patients (18-80 years of age) with need for post-pyloric feeding (patients unable to eat due to stroke, intubated patients with respiratory failure, patients with acute pancreatitis, etc).
  • Ability to give informed consent.
Exclusion Criteria
  • Unable to give informed consent
  • Pregnant or breastfeeding women (all women of child-bearing age will undergo urine pregnancy testing)
  • Acute gastrointestinal bleeding
  • Coagulopathy defined by prothrombin time < 50% of control; PTT > 50 sec, or INR > 1.5), on chronic anticoagulation, or platelet count <50,000
  • Inability to tolerate sedated upper endoscopy due to cardio-pulmonary instability or other contraindication to endoscopy
  • Cirrhosis with portal hypertension, varices, and/or ascites
  • Allergy to egg

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Self-propelled PEGJ feeding tubePEG-J placementPatients in this arm will receive self-propelled balloon PEGJ tube.
Standard PEGJ feeding tubePEG-J placementPatients in this arm will receive the standard commercially availabel PEGJ tube.
Primary Outcome Measures
NameTimeMethod
Number of Participants With PEG-J Tube MigrationFrom date of placement up to 4 weeks

Number of participants in whom migration was assessed by X-ray at 4 weeks post-intervention.

Secondary Outcome Measures
NameTimeMethod
Patency of Feeding Tube2 years

Determine tube patency which is defined as time period between tube placement and need for re-intervention.

Technical SuccessIntra-procedural

Success of tube placement in the desired location as determined endoscopically.

Intervention TimeIntra-procedural

Time required from introduction of the upper endoscope until placement of the feeding tube.

Time to Repeat Endoscopy for Tube Replacement2 years

If repeate endocopy and tube placement are needed due to clogging or retrograde migration

Long-term Complications2 years

Long-term complications will include stomal (Infection, erythema, bleeding, pain, secretion, abscess, etc) and tube (Clotting, dislocation, defect and aspiration, etc) complications detected more than one week after intervention.

Repeat Endoscopy for Feeding Tube Placement Due to Retrograde Tube Migration4 weeks

Patiens who will have retrograde PEG-J tube migration will get repeat endoscopy for PEG-J tube placement

Difficulty of the ProcedureInra-procedural

Scored by the endoscopist on a 10-point Visual Analogue Scale with zero being "without difficulty" and 10 being "maximum difficulty".

The lower the score, the better the outcome.

Gastrointestinal Quality of Life Index (GIQLI) Score3 month

Gastrointestinal Quality of Life Index (GIQLI) score ranging from 0 (worst quality of life possible with severe digestive symptoms) to 144 (optimal quality of life without symptoms

Short-term ComplicationsOne week

Short-term complications will include stomal (Infection, erythema, bleeding, pain and secretion, etc) and tube (Clotting, dislocation, defect, aspiration, etc) complications detected in the first week.

Direct Cost2 years

Cost will be determined according to Medicare reimbursement of billed CPT codes. The cost of all related follow-up procedures will be included (e.g. cost of standard PEGJ in case of failed Self-propelled PEGJ feeding tube, cost of managing complications, cost of re-intervention in case of tube dysfunction, etc)

Trial Locations

Locations (1)

Johns Hopkins Hospital

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath